|
시장보고서
상품코드
1671071
세계의 수막염 진단 및 치료 시장 - 규모, 점유율, 동향, 산업 분석 보고서 : 유형별, 치료 및 진단별, 최종 사용자별, 지역별 예측(2025-2034년)Meningitis Diagnosis and Treatment Market Size, Share, Trends, Industry Analysis Report: By Type, Treatment & Diagnosis, End User, and Region - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research사의 최신 조사에 따르면 수막염 진단 및 치료 시장 규모는 2034년까지 1억 7,901만 달러에 이를 전망입니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.
수막염 진단 및 치료 시장은 수막염, 특히 세균성 수막염의 유병률이 증가하고 신속하고 정확한 진단 솔루션에 대한 수요가 증가함에 따라 견인되고 있습니다. 분자진단학의 진보와 진단 과정에서 AI의 통합은 효과적인 치료에 필수적인 병원체 동정의 속도와 정확성을 향상시킵니다. 특히 신흥의 수막염주에 대한 백신 개발에 중점을 두고 있는 것은 시장 개척의 큰 기회가 되고 있습니다.
게다가, 충분한 서비스를 받지 못한 지역에서의 백신접종 프로그램의 확대와 수막염 예방에 관한 일반 시민의 의식의 고조는 시장 확대의 추가 원동력이 되고 있습니다. 시장은 표적요법의 개발, 진단기술의 향상, 세계의 헬스케어 격차에 대한 대처의 진행 등 동향을 목격하고 있습니다. 기술 혁신과 치료에 대한 광범위한 접근을 지속적으로 추진함으로써 시장은 앞으로 수년간 안정적인 성장을 이룰 것으로 보입니다.
수막염 진단, 치료 시장 보고서, 하이라이트
세균성 수막염 분야는 질병의 중증도와 적시 치료의 필요성으로 시장을 독점하고 있지만, 인지도의 향상과 진단의 개선에 의해 바이러스성 수막염이 가장 급성장하고 있는 분야입니다.
치료 분야는 항생제와 백신의 높은 수요에 의해 최대 점유율을 차지하고 있으며, 진단 분야는 분자진단과 AI 기술의 진보로 가장 높은 성장을 이루고 있습니다.
병원 및 진료소는 수막염 진단 및 치료의 주요 장소로서 시장을 선도하고 있으며, 진단 실험실이나 외래 진료를 포함한 기타 부문이 가장 높은 성장을 나타내고 있습니다. 이 배경에는 신흥 시장에서의 건강 관리 접근의 확대가 있습니다.
북미는 첨단 건강 관리 인프라와 백신 접종 프로그램을 통해 수막염 진단 및 치료 시장에서 가장 큰 점유율을 차지하고 있으며, 아시아태평양은 신흥 국가에서의 이환율 상승과 건강 관리 확대로 가장 높은 성장을 보이고 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 수막염 진단 및 치료 시장 인사이트
- 시장 현황
- 수막염 진단 및 치료 시장 역학
- 성장 촉진요인과 기회
- AI와 머신러닝의 통합
- 고 처리량 실험으로 전환
- 억제요인과 과제
- 데이터량 부족
- 성장 촉진요인과 기회
- PESTEL 분석
- 수막염 진단 및 치료 시장의 응용 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 수막염 진단 및 치료 시장 : 유형별
- 주요 조사 결과
- 소개
- 바이러스성 수막염
- 세균성 수막염
- 기타
제6장 세계의 수막염 진단 및 치료 시장 : 치료 및 진단별
- 주요 조사 결과
- 소개
- 치료
- 진단
제7장 세계의 수막염 진단 및 치료 시장 : 최종 사용자별
- 주요 조사 결과
- 소개
- 병원 및 클리닉
- 기타
제8장 세계의 수막염 진단 및 치료 시장 :지역
- 주요 조사 결과
- 소개
- 수막염 진단 및 치료 시장의 평가 : 지역, 2020-2034년
- 북미
- 북미 : 유형별, 2020-2034년
- 북미 : 치료 및 진단별, 2020-2034년
- 북미 : 최종사용자별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별, 2020-2034년
- 유럽 : 치료 및 진단별, 2020-2034년
- 유럽 : 최종사용자별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양: 유형별, 2020-2034년
- 아시아태평양: 치료 및 진단별, 2020-2034년
- 아시아태평양: 최종 사용자별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별, 2020-2034년
- 중동 및 아프리카 : 치료 및 진단별, 2020-2034년
- 중동 및 아프리카 : 최종사용자별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 치료 및 진단별, 2020-2034년
- 라틴아메리카 : 최종사용자별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제9장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 프로파일
- Pfizer Inc.
- Merck & Co., Inc.
- Sanofi SA
- GlaxoSmithKline plc
- Novartis AG
- Johnson & Johnson
- Roche Holding AG
- Abbott Laboratories
- Siemens Healthineers
- bioMerieux SA
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc.
- Mylan NV(now part of Viatris Inc.)
- Hologic, Inc.
- Cepheid, Inc.
The meningitis diagnosis and treatment market size is expected to reach USD 179.01 million by 2034, according to a new study by Polaris Market Research. The report "Meningitis Diagnosis and Treatment Market Size, Share, Trends, Industry Analysis Report: By Type (Viral Meningitis, Bacterial Meningitis, and Others), Treatment & Diagnosis, End User (Hospitals & Clinics and Others), and Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The meningitis diagnosis and treatment market is driven by the rising prevalence of meningitis, particularly bacterial forms, and the increasing demand for rapid, accurate diagnostic solutions. Advancements in molecular diagnostics and the integration of AI in diagnostic processes are enhancing the speed and precision of pathogen identification, which is crucial for effective treatment. The growing focus on vaccine development, particularly for emerging strains of meningitis, presents significant opportunities for market growth.
Additionally, expanding vaccination programs in underserved regions and increasing public awareness about meningitis prevention further fuel market expansion. The market is witnessing trends such as the development of targeted therapies, improved diagnostic technologies, and the ongoing efforts to address global healthcare disparities. With a continuous push toward innovation and broader access to treatments, the market is poised for steady growth in the coming years.
Meningitis Diagnosis and Treatment Market Report Highlights
The bacterial meningitis segment dominates the market due to the severity of the disease and the critical need for timely treatments, although viral meningitis is the fastest-growing segment with increasing awareness and diagnostic improvements.
The treatment segment holds the largest share, driven by the high demand for antibiotics and vaccines, while the diagnosis segment is experiencing the highest growth due to advancements in molecular diagnostics and AI technologies.
Hospitals & clinics lead the market as the primary setting for meningitis diagnosis and treatment, while the others segment, including diagnostic labs and outpatient care, is witnessing the highest growth. This is driven by expanding healthcare access in emerging markets.
North America holds the largest meningitis diagnosis and treatment market share due to advanced healthcare infrastructure and vaccination programs, while Asia Pacific is the highest-growing, fueled by rising incidence and healthcare expansion in developing countries.
Polaris Market Research has segmented the meningitis diagnosis and treatment market report based on type, treatment & diagnosis, end user, and region:
By Type Outlook (Revenue-USD Million, 2020 - 2034)
- Viral Meningitis
- Bacterial Meningitis
- Others
By Treatment & Diagnosis Outlook (Revenue-USD Million, 2020 - 2034)
- Treatment
- Diagnosis
By End-User Outlook (Revenue-USD Million, 2020 - 2034)
- Hospitals & Clinics
- Others
By Regional Outlook (Revenue-USD Million, 2020 - 2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
4. Global Meningitis Diagnosis and Treatment Market Insights
- 4.1. Meningitis Diagnosis and Treatment Market - Market Snapshot
- 4.2. Meningitis Diagnosis and Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Integration of AI and Machine Learning
- 4.2.1.2. Shift Toward High-Throughput Experimentation
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Insufficient data volume
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Meningitis Diagnosis and Treatment Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Meningitis Diagnosis and Treatment Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 5.3. Viral Meningitis
- 5.3.1. Global Meningitis Diagnosis and Treatment Market, by Viral Meningitis, by Region, 2020-2034 (USD Million)
- 5.4. Bacterial Meningitis
- 5.4.1. Global Meningitis Diagnosis and Treatment Market, by Bacterial Meningitis, by Region, 2020-2034 (USD Million)
- 5.5. Others
- 5.5.1. Global Meningitis Diagnosis and Treatment Market, by Others, by Region, 2020-2034 (USD Million)
6. Global Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 6.3. Treatment
- 6.3.1. Global Meningitis Diagnosis and Treatment Market, by Treatment, by Region, 2020-2034 (USD Million)
- 6.4. Diagnosis
- 6.4.1. Global Meningitis Diagnosis and Treatment Market, by Diagnosis, by Region, 2020-2034 (USD Million)
7. Global Meningitis Diagnosis and Treatment Market, by End-User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 7.3. Hospitals & Clinics
- 7.3.1. Global Meningitis Diagnosis and Treatment Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
- 7.4. Others
- 7.4.1. Global Meningitis Diagnosis and Treatment Market, by Others, by Region, 2020-2034 (USD Million)
8. Global Meningitis Diagnosis and Treatment Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Meningitis Diagnosis and Treatment Market Assessment, By Geography, 2020-2034 (USD Million)
- 8.3. Meningitis Diagnosis and Treatment Market - North America
- 8.3.1. North America: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.3.2. North America: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.3.3. North America: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.3.4. Meningitis Diagnosis and Treatment Market - U.S.
- 8.3.4.1. U.S.: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.3.4.2. U.S.: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.3.4.3. U.S.: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.3.5. Meningitis Diagnosis and Treatment Market - Canada
- 8.3.5.1. Canada: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.3.5.2. Canada: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.3.5.3. Canada: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.4. Meningitis Diagnosis and Treatment Market - Europe
- 8.4.1. Europe: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.4.2. Europe: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.4.3. Europe: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.4.4. Meningitis Diagnosis and Treatment Market - UK
- 8.4.4.1. UK: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.4.4.2. UK: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.4.4.3. UK: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.4.5. Meningitis Diagnosis and Treatment Market - France
- 8.4.5.1. France: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.4.5.2. France: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.4.5.3. France: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.4.6. Meningitis Diagnosis and Treatment Market - Germany
- 8.4.6.1. Germany: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.4.6.2. Germany: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.4.6.3. Germany: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.4.7. Meningitis Diagnosis and Treatment Market - Italy
- 8.4.7.1. Italy: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.4.7.2. Italy: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.4.7.3. Italy: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.4.8. Meningitis Diagnosis and Treatment Market - Spain
- 8.4.8.1. Spain: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.4.8.2. Spain: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.4.8.3. Spain: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.4.9. Meningitis Diagnosis and Treatment Market - Netherlands
- 8.4.9.1. Netherlands: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.4.9.2. Netherlands: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.4.9.3. Netherlands: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.4.10. Meningitis Diagnosis and Treatment Market - Russia
- 8.4.10.1. Russia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.4.10.2. Russia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.4.10.3. Russia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.4.11. Meningitis Diagnosis and Treatment Market - Rest of Europe
- 8.4.11.1. Rest of Europe: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.4.11.2. Rest of Europe: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.4.11.3. Rest of Europe: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.5. Meningitis Diagnosis and Treatment Market - Asia Pacific
- 8.5.1. Asia Pacific: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.5.4. Meningitis Diagnosis and Treatment Market - China
- 8.5.4.1. China: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.5.4.2. China: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.5.4.3. China: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.5.5. Meningitis Diagnosis and Treatment Market - India
- 8.5.5.1. India: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.5.5.2. India: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.5.5.3. India: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.5.6. Meningitis Diagnosis and Treatment Market - Malaysia
- 8.5.6.1. Malaysia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.5.6.2. Malaysia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.5.6.3. Malaysia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.5.7. Meningitis Diagnosis and Treatment Market - Japan
- 8.5.7.1. Japan: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.5.7.2. Japan: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.5.7.3. Japan: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.5.8. Meningitis Diagnosis and Treatment Market - Indonesia
- 8.5.8.1. Indonesia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.5.8.2. Indonesia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.5.8.3. Indonesia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.5.9. Meningitis Diagnosis and Treatment Market - South Korea
- 8.5.9.1. South Korea: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.5.9.2. South Korea: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.5.9.3. South Korea: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.5.10. Meningitis Diagnosis and Treatment Market - Australia
- 8.5.10.1. Australia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.5.10.2. Australia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.5.10.3. Australia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.5.11. Meningitis Diagnosis and Treatment Market - Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.5.11.2. Rest of Asia Pacific: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.5.11.3. Rest of Asia Pacific: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.6. Meningitis Diagnosis and Treatment Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.6.4. Meningitis Diagnosis and Treatment Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.6.4.2. Saudi Arabia: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.6.4.3. Saudi Arabia: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.6.5. Meningitis Diagnosis and Treatment Market - UAE
- 8.6.5.1. UAE: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.6.5.2. UAE: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.6.5.3. UAE: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.6.6. Meningitis Diagnosis and Treatment Market - Israel
- 8.6.6.1. Israel: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.6.6.2. Israel: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.6.6.3. Israel: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.6.7. Meningitis Diagnosis and Treatment Market - South Africa
- 8.6.7.1. South Africa: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.6.7.2. South Africa: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.6.7.3. South Africa: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.6.8. Meningitis Diagnosis and Treatment Market - Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.6.8.2. Rest of Middle East & Africa: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.6.8.3. Rest of Middle East & Africa: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.7. Meningitis Diagnosis and Treatment Market - Latin America
- 8.7.1. Latin America: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.7.2. Latin America: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.7.3. Latin America: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.7.4. Meningitis Diagnosis and Treatment Market - Mexico
- 8.7.4.1. Mexico: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.7.4.2. Mexico: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.7.4.3. Mexico: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.7.5. Meningitis Diagnosis and Treatment Market - Brazil
- 8.7.5.1. Brazil: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.7.5.2. Brazil: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.7.5.3. Brazil: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.7.6. Meningitis Diagnosis and Treatment Market - Argentina
- 8.7.6.1. Argentina: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.7.6.2. Argentina: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.7.6.3. Argentina: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
- 8.7.7. Meningitis Diagnosis and Treatment Market - Rest of Latin America
- 8.7.7.1. Rest of Latin America: Meningitis Diagnosis and Treatment Market, by Type, 2020-2034 (USD Million)
- 8.7.7.2. Rest of Latin America: Meningitis Diagnosis and Treatment Market, by Treatment & Diagnosis, 2020-2034 (USD Million)
- 8.7.7.3. Rest of Latin America: Meningitis Diagnosis and Treatment Market, by End-User, 2020-2034 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Pfizer Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Merck & Co., Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Sanofi S.A.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. GlaxoSmithKline plc
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Novartis AG
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Johnson & Johnson
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Roche Holding AG
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Abbott Laboratories
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Siemens Healthineers
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. bioMerieux S.A.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Becton, Dickinson and Company
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Thermo Fisher Scientific Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Mylan N.V. (now part of Viatris Inc.)
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Hologic, Inc.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Cepheid, Inc.
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
02-2025-2992
(주말 및 공휴일 제외)
(주말 및 공휴일 제외)
※ 부가세 별도
검색
샘플 요청 목록